Annual report pursuant to Section 13 and 15(d)

Balance Sheets

v2.4.0.6
Balance Sheets (USD $)
Sep. 30, 2011
Sep. 30, 2010
CURRENT ASSETS    
Cash $ 469,786 $ 422,414
Prepaid expenses 37,611 34,889
Grant receivable 179,358 65,122
Security deposits    85,025
Other current assets 5,000   
Total Current Assets 691,755 607,450
EQUIPMENT, net 19,164 24,168
OTHER ASSETS    
Patent costs, net 701,927 780,407
TOTAL ASSETS 1,412,846 1,412,025
CURRENT LIABILITIES    
Accounts payable and accrued expenses 301,055 338,225
Short-term notes payable    17,486
Convertible debentures    51,115
Stock warrant derivative liability 5,893,544 1,387,656
Total Current Liabilities 6,194,599 1,794,482
TOTAL LIABILITIES 6,194,599 1,794,482
STOCKHOLDERS' EQUITY (DEFICIT)    
Preferred stock, Series B; 6,000,000 shares authorized, at $0.0001 par value, 5,583,336 and 5,583,336 shares issued and outstanding, respectively 558 558
Common stock; 180,000,000 shares authorized, at $0.0001 par value, 39,702,580 and 35,452,580 shares issued and outstanding, respectively 3,970 3,545
Additional paid-in capital 22,289,231 21,587,433
Accumulated deficit (21,628,748) (21,628,748)
Deficit accumulated during the development stage (5,446,764) (345,245)
Total Stockholders' Equity (Deficit) (4,781,753) (382,457)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) $ 1,412,846 $ 1,412,025